Various thienopyrimidine-based analog compounds that selectively inhibit the Src family of tyrosine kinases. These compounds are thienopyrimidines and contain a hydrozone bridge created by heating a thienopyrimidine hydrazine with an aldehyde in ethanol at reflux. Such compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections.
各种基于
噻唑嘧啶的类似化合物,可以选择性地抑制Src
酪氨酸激酶家族。这些化合物是
噻唑嘧啶,并含有由在
乙醇中回流时将
噻唑嘧啶肼和醛加热而形成的羟
肼桥。这些化合物可用于治疗各种疾病,包括增生性疾病、血液学疾病、骨质疏松症、神经系统疾病、自身免疫疾病、过敏/免疫疾病或病毒感染。